Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases
Clinical Reviews in Allergy and Immunology, 06/30/09
Ishii N et al. - Randomized controlled trials are necessary to better determine the efficacy and adverse effects of IVIG in the treatment of autoimmune bullous skin diseases. In addition, insights into IVIG's mode of action might enable us to develop novel therapeutics to overcome the current shortage of IVIG.
Related Articles
Linear immunoglobulin A bullous dermatosis
Expert Review of Dermatology, 10/14/09
Relevance Score: 66%
Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 64%
Prevalence and distribution of solitary oral pigmented lesions: a prospective study
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 63%
Antiretroviral-induced toxic epidermal necrolysis in a patient positive for human immunodeficiency virus
Clinical and Experimental Dermatology, 10/08/09
Relevance Score: 63%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 47%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with the PPAR-gamma agonist rosiglitazone down-regulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
European Journal of Endocrinology, 11/24/09
Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis
Expert Review of Clinical Immunology, 11/23/09
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria
British Journal of Dermatology, 11/24/09
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, 11/24/09
An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment
Dermatologic Therapy, 11/20/09
Today in Rheumatic/Autoimmune...keeping you current
Receive free subspecialty "5-minute updates" via email
Update in treatment options for psoriatic arthritis
Expert Review of Clinical Immunology, 11/23/09
Adalimumab for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology, 11/19/09
Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
BMC Musculoskeletal Disorders, 11/18/09
Sponsor
Article Search
Sponsor